menu

Medical Program: Genetic Testing for Psychiatric Disorders: Is It Ready for Primetime?

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Genetic Testing for Psychiatric Disorders: Is It Ready for Primetime?

close
Genetic Testing for Psychiatric Disorders: Is It Ready for Primetime?
Restart
Resume
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    Psychopharmacology is the study of genetic variations to pinpoint more effective personalized treatments for psychiatric disorders. But with clinicians, industry heads, insurance providers, and regulating agencies all weighing in on this practice and forming varying opinions, what’s the best way to move forward? Here to answer that question and others with Dr. Mimi Secor is Dr. James Potash, a Professor of Psychiatry and Behavioral Sciences and Psychiatrist in Chief at the John Hopkins Department of Psychiatry. 

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Psychopharmacology is the study of genetic variations to pinpoint more effective personalized treatments for psychiatric disorders. But with clinicians, industry heads, insurance providers, and regulating agencies all weighing in on this practice and forming varying opinions, what’s the best way to move forward? Here to answer that question and others with Dr. Mimi Secor is Dr. James Potash, a Professor of Psychiatry and Behavioral Sciences and Psychiatrist in Chief at the John Hopkins Department of Psychiatry. 

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 8/15/20